24th Annual Symposium of The Protein Society

第24届蛋白质学会年度研讨会

• 批准号: 8007496
• 负责人: ARTHUR G PALMER
• 金额: $ 0.5万
• 依托单位: PROTEIN SOCIETY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8007496
• 关键词: Amyloidosis; Area; Award; Biochemistry; Biophysics; California; Cells; Cellular biology; Collaborations; Communicable Diseases; Country; Development; Diagnostic; Disease; Drug Formulations; Fostering; Goals; Health; Heart Diseases; Human; Image; Industry; Malignant Neoplasms; Membrane Proteins; Metalloproteins; Microfluidics; Neurodegenerative Disorders; Oral; Play; Postdoctoral Fellow; Protein Engineering; Proteins; Research; Research Personnel; Role; Schedule; Senior Scientist; Societies; Solubility; Therapeutic; Translational Research; Universities; Utah; Wisconsin; Woman; abstracting; base; design; graduate student; lecturer; lectures; medical schools; meetings; new technology; posters; programs; protein complex; protein folding; public health relevance; reconstitution; symposium; therapeutic protein

DESCRIPTION (provided by applicant): The 24th Symposium of The Protein Society will be held August 1-5, 2010 at the Manchester Grand Hyatt in San Diego, California - organized by David P. Goldenberg (University of Utah). The meeting theme is Looking at Proteins: Expanding Perspectives & New Technologies. Two Plenary Sessions will feature "Macromolecular Machines" and a memorial session honoring Frederic Richards. The 2010 Society Awards will be presented in two Awards Plenary Sessions, and awardees will present plenary lectures. Scientific sessions will focus on Protein Engineering for Solubility and Reconstitution, Imaging and Deconstructing Large Complexes, Protein Stability and Drug Formulation, Visualizing Proteins in Cells, Protein Therapeutics and Diagnostics, Disordered Proteins, Protein Folding, Membrane Proteins and Receptors, Microfluidics and Microarrays, Metalloproteins, Protein Design, and Amyloids and Disease. Lecturers, including both high profile senior investigators (e.g., Frances Arnold (Caltech), David Eisenberg (UCLA), Carlos Bustamante (UC, Berkeley), Silvia Cavagnero (Univ of Wisconsin- Madison), Martha Bulyk (Harvard Medical School-MIT), and Tomi Sawyer (Aileron Therapeutics, Inc.), etc.) and junior investigators, were chosen on the basis of their outstanding research programs. In addition, the program is highly diverse with women and other underrepresented groups comprising approximately one third of the invited speakers. Our goal is to appeal to an expanded audience of researchers in biomedical fields where proteins play an important role, ranging from basic biochemistry to human therapeutics. Many of our symposia cover topics with direct relevance to broad areas of human health and disease: neurodegenerative disorders, cancer, infectious diseases, and heart disease. The symposium is planned for approximately 1,300 attendees, including undergraduate and graduate students, postdoctoral fellows, as well as junior and senior scientists from the U.S. and other countries. Approximately 300 graduate students and 200 postdoctoral fellows are expected to attend the meeting. Oral sessions include invited speakers and promoted poster talks. Fifteen plenary talks, 60 invited speakers and 30 promoted poster talks are scheduled during the meeting. The poster sessions include a total of approximately 400 posters. Approximately 700 abstract submissions are anticipated. Promoted poster talks are chosen to represent late-breaking developments and to provide an opportunity for undergraduate and graduate students as well as postdoctoral fellows to speak at the meeting. 1 PUBLIC HEALTH RELEVANCE: Our goal is to appeal to an expanded audience of researchers in biomedical fields where proteins play an important role, ranging from basic biochemistry and biophysics to cell biology to human therapeutics. Many of our symposia cover topics with direct relevance to broad areas of human health and disease: neurodegenerative disorders, cancer, infectious diseases, and heart disease-in scientific sessions focusing on Protein Engineering for Solubility and Reconstitution, Imaging and Deconstructing Large Complexes, Protein Stability and Drug Formulations, Visualizing Proteins in Cells, Protein Therapeutics and Diagnostics, Disordered Proteins, Protein Folding, Membrane Proteins and Receptors, Microfluidics and Microarrays, Metalloproteins, Protein Design, Amyloids and Disease, and Macromolecular Machines. We also have a number of speakers from industry, which should help to foster contacts and collaborations leading to translational research efforts. 1

描述（由申请人提供）：蛋白质协会第24届研讨会将于2010年8月1日至5日在加州圣地亚哥的曼彻斯特君悦酒店举行-由大卫P.戈登伯格（犹他州大学）组织。 会议的主题是“展望蛋白质：拓展视角和新技术”。两次全体会议将以“高分子机器”和纪念弗雷德里克理查兹的纪念会议为特色。2010年社会奖将在两个奖项全体会议，获奖者将提出全体讲座。科学会议将集中在蛋白质工程的溶解度和重建，成像和解构大型复合物，蛋白质稳定性和药物制剂，可视化蛋白质在细胞中，蛋白质治疗和诊断，无序蛋白质，蛋白质折叠，膜蛋白质和受体，微流体和微阵列，金属蛋白，蛋白质设计，和淀粉样蛋白和疾病。讲师，包括高知名度的高级研究人员（例如，Frances Arnold（加州理工学院）、大卫艾森伯格（加州大学洛杉矶分校）、卡洛斯布斯塔曼特（加州大学伯克利分校）、Silvia Cavagnero（威斯康星州-麦迪逊大学）、Martha Bulyk（哈佛医学院-麻省理工学院）和Tomi索耶（副翼治疗公司），等等）。和初级研究人员，是根据他们杰出的研究项目选择的。此外，该方案高度多样化，妇女和其他代表性不足的群体约占受邀发言人的三分之一。我们的目标是吸引更多的生物医学领域的研究人员，从基础生物化学到人类治疗学，蛋白质在这些领域发挥着重要作用。我们的许多专题讨论会涵盖与人类健康和疾病的广泛领域直接相关的主题：神经退行性疾病，癌症，传染病和心脏病。研讨会计划约1,300名与会者，包括本科生和研究生，博士后研究员，以及来自美国和其他国家的初级和高级科学家。预计约有300名研究生和200名博士后研究员参加会议。口头会议包括特邀演讲者和推广海报演讲。会议期间安排了15场全体会议、60场特邀演讲和30场宣传海报演讲。海报会议共包括约400张海报。预计将提交约700份摘要。选择推广海报会谈代表最新的发展，并为本科生和研究生以及博士后研究员提供在会议上发言的机会。1 公共卫生关系：我们的目标是吸引更多的生物医学领域的研究人员，其中蛋白质发挥着重要作用，从基础生物化学和生物物理学到细胞生物学再到人类治疗学。我们的许多研讨会涵盖与人类健康和疾病的广泛领域直接相关的主题：神经退行性疾病，癌症，传染病和心脏病-在科学会议上集中在蛋白质工程的溶解性和重建，成像和解构大复合物，蛋白质稳定性和药物制剂，可视化蛋白质在细胞中，蛋白质治疗和诊断，无序蛋白质，蛋白质折叠，膜蛋白和受体，微流体和微阵列，金属蛋白，蛋白质设计，淀粉样蛋白和疾病，和高分子机器。我们还有一些来自行业的演讲者，这应该有助于促进接触和合作，从而促进转化研究工作。1